Login
$LONA
$4.76 -$0.08 (1.65%) Close

$LONA SEC Filings

Filed On Filing
26 Oct 2026 Form 4: Perceptive Advisors Llc, Director and 2 others

Received 776,648 shares by exercise or conversion ($777)

26 Oct 2026 SCHEDULE 13D/A
22 Sep 2026 8-K: Other Events

In December 2025, as part of a private placement, LeonaBio, Inc. (the “Company”) issued warrants to purchase an aggregate of 23,031,494 shares of its common stock (the “Series A Common Warrants”). The Series A Common Warrants have an exe...

03 Sep 2026 Form 3: Portman David J., 10% owner
31 Aug 2026 SCHEDULE 13D
26 Aug 2026 8-K: Other Events
25 Aug 2026 SCHEDULE 13D/A
20 Aug 2026 SCHEDULE 13G/A
14 Aug 2026 10-Q
14 Aug 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
10 Jul 2026 Form 4: Perceptive Advisors Llc, Director and 2 others

Granted 28,000 Stock Option (Right to Buy)

09 Jul 2026 Form 4: Perceptive Advisors Llc, Director and 2 others

Granted 28,000 Stock Option (Right to Buy)

24 Jun 2026 Form 4: Callori Fred, Director

Granted 2,333 Stock Option (Right to Buy)

24 Jun 2026 Form 4: Holles Natalie C., Director

Granted 2,333 Stock Option (Right to Buy)

24 Jun 2026 Form 4: Silverman Peter B., Director

Granted 2,333 Stock Option (Right to Buy)

24 Jun 2026 Form 4: Panzara Michael A., Director

Granted 28,000 Stock Option (Right to Buy)

24 Jun 2026 Form 4: Romano Kelly A, Director

Granted 28,000 Stock Option (Right to Buy)

24 Jun 2026 Form 4: Edelman Joseph, Director

Granted 28,000 Stock Option (Right to Buy)

24 Jun 2026 Form 4: Johnson James A, Director

Granted 28,000 Stock Option (Right to Buy)

24 Jun 2026 Form 4: Kosacz Barbara, Director

Granted 28,000 Stock Option (Right to Buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support